Position in RPRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,990
+$2,592 QoQ
Shares Held
89
+78.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#601
of 641 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kilter Group LLC holds $136,608 across 30 Biotechnology names. RPRX ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
122 | $60,601 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28 | $17,459 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
114 | $8,922 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
73 | $5,954 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
89 | $4,990 | |
| 6 | GMAB |
Genmab A/S
|
179 | $4,917 | |
| 7 | ARGX |
Argenx SE
|
5 | $4,638 | |
| 8 | AVXL |
Anavex Life Sciences Corp.
|
1,597 | $4,136 |
All Filings in RPRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,990 | 89 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,398 | 50 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,932 | 50 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,764 | 50 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $1,801 | 50 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||